These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 6528616

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Experiences with the substitution of antithrombin III concentrates in congenital and acquired deficiency disorders].
    Schramm W.
    Behring Inst Mitt; 1983 Aug; (73):66-78. PubMed ID: 6332613
    [Abstract] [Full Text] [Related]

  • 5. Severe antithrombin III deficiency in a patient with pre-eclampsia. Observations on the effect of human AT III concentrate transfusion.
    Büller HR, Weenink AH, Treffers PE, Kahlé LH, Otten HA, ten Cate JW.
    Scand J Haematol; 1980 Jul; 25(1):81-6. PubMed ID: 7444377
    [Abstract] [Full Text] [Related]

  • 6. [Antithrombin III in various conditions in internal medicine].
    Malý J, Pecka M, Pidrman V, Zadák Z, Gregor J, Jebavý L, Bláha M, Siroký O.
    Vnitr Lek; 1997 Oct; 43(10):645-8. PubMed ID: 9601877
    [Abstract] [Full Text] [Related]

  • 7. [Anti-coagulant therapy--antithrombin III].
    Tsuji H.
    Rinsho Ketsueki; 1990 Jun; 31(6):750-5. PubMed ID: 2214165
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Etiology, clinical significance and therapy of antithrombin III deficiencies].
    Lechner K, Thaler E, Niessner H.
    Acta Med Austriaca; 1983 Jun; 10(5):129-35. PubMed ID: 6666509
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Replacement therapy of acquired antithrombin III deficiency in experimental nephrotic syndrome].
    Bashkov GV, Kalishevskaia TM.
    Biull Eksp Biol Med; 1987 Sep; 104(9):278-81. PubMed ID: 3663906
    [Abstract] [Full Text] [Related]

  • 14. [Significance of antithrombin III in kidney diseases].
    Schrader J, Köstering H, Scheler F.
    Behring Inst Mitt; 1986 Feb; (79):216-30. PubMed ID: 3718408
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Antithrombin III substitution in dialysis-dependent renal insufficiency].
    Schrader J, Köstering H, Kramer P, Scheler F.
    Dtsch Med Wochenschr; 1982 Dec 03; 107(48):1847-50. PubMed ID: 7140568
    [Abstract] [Full Text] [Related]

  • 17. [Acquired antithrombin III deficiency].
    Müller G.
    Z Gesamte Inn Med; 1992 Feb 03; 47(2):74-7. PubMed ID: 1585693
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Treatment with AT III concentrates in hereditary and acquired AT III deficiency.
    Gromnica-Ihle E, Ziemer S.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988 Feb 03; 115(3):307-13. PubMed ID: 2465221
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.